Since ApoE status is tightly associated with amyloid and tau pathology [49], it is possible that the gradient changes we observed in ε4 carriers and participants with higher tau/p-tau levels and lower Aß/p-tau ratio are interlinked. The gene discussed is APOE; the disease is amyloidosis.